Company intelligence / Profile preview

Kayentis

Meylan, Auvergne-Rhone-Alpes, Francekayentis.com ↗
Ownership
Private
Employees
~185
Development stage
Commercial
01

Overview

Kayentis has enabled digital data collection in over 300 clinical trials across more than 90 countries and in over 120 languages. Its technology streamlines patient engagement and data quality for sponsors and CROs globally. The company’s Clin’form platform supports both decentralized and on-site studies with high-quality datasets and user-friendly interfaces.

Therapeutic areas
Other
Modalities
DeviceSoftwareDigital health solution
Industry
Biomedical IT and Biomedical Data Platforms
02

Partnerships

ClinOneOMRON HealthcareOmniCommSecureConsenteNFORME

Beyond the preview

Go deeper on Kayentis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kayentis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call